Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve 1. The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and Half Year ended on 30th September, 2026, in accordance with Regulation 33 of the SEBI Listing Regulation. 2. Any other matter with the permission of the chair.

Date: 02nd November, 2026 Corporate Services Department, BSE Limited, Phiroze Jeejeebhoy Towers, 1st Floor, Dalal Street, Fort, Mumbai - 400001. Scrip Code: 540204 Sub: Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, This is to inform you that as required under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of Board of Directors of the Company is scheduled to be held on Thursday, 05th November, 2026 inter-alia, to consider and approve the following: 1. The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and Half Year ended on 30th September, 2026, in accordance with Regulation 33 of the SEBI Listing Regulation. 2. Any other matter with the permission of the chair. Further, pursuant to the Code of Conduct to Regulate, Monitor and Report Trading by Directors, Promoters, Designated Employees and Connected Persons of the Company and pursuant to SEBI (Prohibition of insider Trading) Regulations 2015, the Trading Window for dealing in securities of the Company for all the Designated Persons is already closed with effect from 01st October, 2026, which shall continue to remain closed for all the Designated Persons and their Immediate Relatives till 48 hours after the declaration of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on 30th September, 2026. Kindly take note of the same and acknowledge. Thanking you, For EIKO LIFESCIENCES LIMITED Chintan Doshi Company Secretary and Compliance Officer Membership No.: A36190 Eiko LifeSciences Limited CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Phone No.: +919082668855; Email id: investor.relations@eikolifesciences.com: website:www.eikolifesciences.com